At a mechanistic level, it is now well-established that tumorigenic crosstalk occurs between the estrogen receptor (ER) axis and epithelial signal transduction downstream of activated IGF1R, and that this crosstalk plays a role in both HR+ breast cancer development and progression [52–55]. The gene discussed is ESR1; the disease is breast carcinoma.